Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Why, why, why de-lupus (does so badly in clinical trials).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Why, why, why de-lupus (does so badly in clinical trials).
Why, why, why de-lupus (does so badly in clinical trials). Expert Rev Clin Immunol. 2016; 12(2):95-8.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Antirheumatic Agents
Clinical Trials as Topic
Clinical Trials as Topic
Drug Therapy, Combination
Drug Therapy, Combination
Humans
Humans
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Recombinant Fusion Proteins
Recombinant Fusion Proteins
Rituximab
Rituximab
Treatment Failure
Treatment Failure
authors with profiles
Joan Merrill